Karmanos Cancer Institute ( Site 0712) — Detroit, Michigan

Karmanos Cancer Institute ( Site 0712) is a clinical research site located in Detroit, Michigan, United States 48201.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Karmanos Cancer Institute ( Site 0712) has participated in 1 clinical trials.

Therapeutic areas: Urothelial Carcinoma.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Karmanos Cancer Institute ( Site 0712)?

Karmanos Cancer Institute ( Site 0712) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Karmanos Cancer Institute ( Site 0712) conducted?

Karmanos Cancer Institute ( Site 0712) has 1 clinical trials on record. Their work covers Urothelial Carcinoma.

Is Karmanos Cancer Institute ( Site 0712) accredited by Crixeo Health?

Karmanos Cancer Institute ( Site 0712) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Karmanos Cancer Institute ( Site 0712)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.